Carnegie Investment Counsel’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $220K | Hold |
|
|||||
|
2024
Q2 | $207K | Hold |
|
|||||
|
2024
Q1 | $231K | Sell |
|
|||||
|
2023
Q4 | $201K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $216K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $317K | Sell |
|
|||||
|
2021
Q1 | $305K | Buy |
|
|||||
|
2020
Q4 | $309K | Buy |
|
|||||
|
2020
Q3 | $289K | Hold |
|
|||||
|
2020
Q2 | $313K | Hold |
|
|||||
|
2020
Q1 | $291K | Hold |
|
|||||
|
2019
Q4 | $361K | Buy |
|
|||||
|
2019
Q3 | $284K | Sell |
|
|||||
|
2019
Q2 | $376K | Hold |
|
|||||
|
2019
Q1 | $392K | Buy |
|
|||||
|
2018
Q4 | $303K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $301K | Hold |
|
|||||
|
2018
Q1 | $302K | Sell |
|
|||||
|
2017
Q4 | $362K | Sell |
|
|||||
|
2017
Q3 | $3.63M | Sell |
|
|||||
|
2017
Q2 | $5.63M | Sell |
|
|||||
|
2017
Q1 | $6.26M | Buy |
|
|||||
|
2016
Q4 | $5.02M | Sell |
|
|||||
|
2016
Q3 | $6.2M | Buy |
|
|||||
|
2016
Q2 | $3.4M | Buy |
|
|||||
|
2016
Q1 | $1.35M | Sell |
|
|||||
|
2015
Q4 | $1.38M | Buy |
|
|||||
|
2015
Q3 | $1.32M | Sell |
|
|||||
|
2015
Q2 | $1.45M | Buy |
|
|||||
|
2015
Q1 | $1.4M | Buy |
|
|||||
|
2014
Q4 | $1.06M | Sell |
|
|||||
|
2014
Q3 | $1.18M | Buy |
|
|||||
|
2014
Q2 | $234K | Sell |
|
|||||
|
2014
Q1 | $255K | Hold |
|
|||||
|
2013
Q4 | $255K | Hold |
|
|||||
|
2013
Q3 | $239K | Hold |
|
|||||
|
2013
Q2 | $238K | Buy |
|